Search research articles
Contact Us
Filters
Showing results (331-340 of 334) with videos related to
Page
of 34
Sort By:
You have reached the last page of results.
This site can display upto 334 results.
International Journal of Cardiology
|
March 18, 2015
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk
Andreas Tomaschitz, Stefan Pilz, Jutta Rus-Machan, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 26, 2003
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER
Carl Erik Mogensen, Giancarlo Viberti, Serge Halimi, et al.
Journal of the American Society of Nephrology : JASN
|
August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations
Marc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Journal of Hypertension
|
April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial
Andreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Page
of 34
Search research articles
Search
Showing results (331-340 of 334) with videos related to
Sort By:
Page
of 34
You have reached the last page of results.
This site can display upto 334 results.
International Journal of Cardiology
|
March 18, 2015
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk
Andreas Tomaschitz, Stefan Pilz, Jutta Rus-Machan, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 26, 2003
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER
Carl Erik Mogensen, Giancarlo Viberti, Serge Halimi, et al.
Journal of the American Society of Nephrology : JASN
|
August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations
Marc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Journal of Hypertension
|
April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial
Andreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.
Page
of 34